GLS and non-small cell lung carcinoma: Similar inhibitory effects on the growth of NSCLC cells were also observed following treatment with our previously reported GAC-specific inhibitor, 968 (Fig. 1e).12 These data suggest that GAC plays a crucial role in NSCLC development and progression.